Clinical Trial Update: A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing postoperative adjuvant therapy with Uracil-tegafur (UFT) versus cyclophosphamide/methotrexate/5-fluorouracil (CMF) has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• METHOTREXATE (METHOTREXATE)
• Uracil-tegafur (uracil-tegafur)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED